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Abstract We report a 16-year-old girl in whom Takayasu
arteritis (TA) was manifested mainly by severe arterial hyper-
tension on her right arm, which was detected during a routine
examinationatschool.Hersystolicbloodpressureontheright
arm was significantly higher than that on the left one. There
was also a pressure difference between the right arm and legs.
The pulse of the left external carotid artery and that of
the left radial artery was absent. Vascular bruits over
interscapular and right supra- and subclavian areas were
heard on auscultation. The diagnosis of TA was con-
firmed by a spiral computed tomography angiography,
which showed a thickened thoracic aortic wall and nar-
rowing of its lumen. In addition, complete occlusion of
the left common carotid artery and the left subclavian
artery was observed. Conclusion: The rarity of the disorder
and the heterogeneous nature of its clinical manifestation
predispose to a late diagnosis and delayed treatment. Our
reporthighlightsthefactthatthe condition can and doesoccur
in a pediatric population in Europe and hence must be con-
sidered in patients presenting with suggestive symptoms and
signs, especially in young patients with unexplained hyper-
tension. Clinical suspicion and proper imaging are crucial for
the correct diagnosis and management of patients with TA. A




Takayasu arteritis (TA), also known as aortoarteritis and
pulseless disease, is a rare condition. It is a form of granu-
lomatous arteritis, which affects large- and medium-sized
arteries, primarily the aorta and its large branches as well as
proximal portions of pulmonary, coronary, and renal arter-
ies. Initially, there are mononuclear cell infiltrations in the
adventitia and granulomas with Langerhans cells in the
media, followed by disruption of the elastin layer and sub-
sequent massive medial and intimal fibrosis. These lesions
result in segmental stenosis, occlusion, dilatation, and aneu-
rysmal formation in the affected vessels [21]. TA is predom-
inantly a disease of young adults in the second and third
decades of life, but it has also been reported in childhood
and in adults older than 40 years [20, 28, 44]. The youngest
patient described was 6 months old [26], and the oldest one
was 75 years [30]. Females are more likely to be affected
than males. In adults approximately 80% of patients with
TA are women [44], although the female-to-male ratio var-
ied from 9:1 in reports from Japan [27], 6.9:1 in Mexico to
1.2:1 in Israel [8]. In the pediatric population, the female
preponderance is less obvious. A series of studies of TA in
childhood from India and South Africa report a 2:1 female-
to-male ratio [16, 46]. Although the disease has a worldwide
distribution, the incidence is considered to be substantially
greater in regions such as India and East Asia than Europe or
North America. Unfortunately, there are no worthwhile
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DOI 10.1007/s00431-012-1674-zepidemiological studies from these supposedly high inci-
dence countries to support this assertion. According to the
published reports, the worldwide incidence of TA is esti-
mated at 2.6 cases per million population per year [44].
About 200 new cases of TA are registered annually in Japan
[27]. The incidence of TA is estimated to be 2.6 persons per
million population per year in Minnesota Olmsted County
[17]. However, the applicability of this number to the di-
verse population of the USA as a whole is uncertain. The
incidence in Europe overall is reported at one case per
million persons per year [8]. In Sweden, the annual inci-
dence is 1.2 per million [52], whereas in the United King-
dom it is 0.15 case per million per year [44]. The prevalence
of TA in children is unknown. Kerr et al. included about
30% of pediatric patients in their study and reported an
incidence in all ages of 2.6 per million [24]. Although
patients with Takayasu arteritis may present with numerous
clinical manifestations, arterial hypertension is the most
common feature of the disease in both adults and children
[10, 16, 17, 24, 46].
Case report
A 16-year-old Caucasian girl was referred to our hospital
due to elevated arterial blood pressure, which was detected
by chance. Upon admission, the girl was in good general
condition. The physical examination revealed normal phys-
ical and mental development. Her body weight and height
were 49 kg (the10th percentile) and 161 cm (the 25th
percentile), respectively, with a BMI of 18/kg/m
2. Tanner
stage III was recorded. The girl virtually never had any
complaints. However, weakness and fatigability of the upper
left extremity were disclosed by a detailed history. In addi-
tion, we found out that 2 years earlier, difficulties in mea-
surement of blood pressure on her left arm had occurred.
Her family history was unremarkable.
On physical examination, there was no evidence of heart
failure. The heart rate was regular at 90/min. Cardiac sounds
were normal. A soft (grade 2/6) systolic murmur was audi-
ble over the cardiac apex. Vascular bruits over the interscap-
ular and right supra- and the subclavian areas were heard on
auscultation. Neither the liver nor the spleen was enlarged.
The muscles of the upper left extremity were slightly atro-
phic, and their tone was decreased. The pulse of the left
external carotid artery and that of the left radial artery was
absent. The femoral pulses were present and equal. On
admission, a significantly elevated systolic blood pressure
192/77 mmHg on the right arm was observed (systolic blood
pressure above 95th percentile for patient’s age, gender, and
height, and normal diastolic blood pressure), whereas the
measurement of blood pressure on the left arm was difficult
but was about 90/52 mmHg. The blood pressure on right
and left legs was 137/74 and 134/70 mmHg, respectively.
Fundoscopic examination was normal.
Laboratory findings showed an elevated erythrocyte sedi-
mentation rate (ESR) of 46 mm/h (normal value <20 mm/1 h)
and serum C-reactive protein level of 1.13 mg/dl (normal
value <0.5 mg/dl). In addition, anemia (hemoglobin level of
5.75mmol/l)andanincreasedlevelofserumimmunoglobulin
G were detected. The rest of the laboratory investigations,
including serum creatinine, electrolytes, autoantibodies, and
urinalysis, were normal, as well as the ECG and chest X-ray.
The tuberculin test was negative. The renal color Doppler
ultrasound examination was normal. On echocardiography,
except for small mitral valve regurgitation, intracardiac anat-
omy abnormalities were not observed. The left ventricular
walls were not hypertrophied, the left ventricular internal
diastolic dimension was 47.5 mm and remained within the
normal range for the patientsage and weight (37.5–54.7 mm).
Dilatation of the ascending aorta and stenosis of the descend-
ing aorta were visible but without a significant poststenotic
increase in blood flow velocity. The flow in the abdominal
aorta was pulsatile. No prograde blood flow was observed in
the left common carotid and in the left subclavian arteries.
Spiral computed tomography angiography (SCTA) of heart
and aorta (Figs. 1 and 2)s h o w e dat h i c k e n e dt h o r a c i ca o r t i c
wall (2.7–4.5 mm) and narrowing of its lumen. The aortic
measurementsand z score date, according toKaiseretal. [23],
were performed as presented in Table 1. On the basis of
clinical manifestations and angiographic abnormalities, the
diagnosis of TAwas made.
Treatment with prednisone in the initial dose of 60 mg/day
(1.3 mg/kg) was introduced together with given orally meth-
otrexate in a dose of 20 mg/m
2/week. Hypertension was
treated using three medications namely: amlodipine (10 mg/
day), hydrochlorothiazide (12.5 mg twice a day), and carve-
dilol (6.25 mg twice a day). After 3 months, the dose of
prednisone was gradually tapered to 10 mg/day. The metho-
trexate has been maintained at the initial dose. The follow-up
of this girl until now is about 8 months. Initially the hyper-
tensionwasnotwellcontrolled,sotheoptionofstentingofthe
descending thoracic aorta had also been considered. But due
to the fact that nonspecific markers of inflammation were
elevated and this girl had never been treated before, she was
qualified for continued medical treatment. At present, under
treatment, her blood pressure on the right arm varies between
123/70 and 140/96 mmHg and there is no pressure difference
between her right arm and legs. In laboratory tests, C-reactive
protein is only slightly elevated 0.67 mg/dl, ESR is 17 mm/h.
Moreover, an SCTA examination after a couple of
months revealed a similar range of inflammatory changes
within the aorta but the thickness of the infiltration had
been reduced. The patient is currently under a long-term
clinical surveillance by a cardiologist, rheumatologist,
nephrologist, and psychologist.
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Although our knowledge of TA has considerably improved
over the last decade, the etiology and pathogenesis of this
disease still remain controversial. It is now assumed that the
underlying pathogenesis is inflammatory with unknown
etiology. Several etiologic factors have been proposed, in-
cluding spirochetes, Mycobacterium tuberculosis, strepto-
cocci, circulating antibodies due to an autoimmune
process, and genetic aspects [44]. One hypothesis states that
an antigen deposited in vascular walls activates CD4+
T cells, followed by the release of cytokines chemotactic
for monocytes. These monocytes are transformed into mac-
rophages that mediate endothelial damage and granuloma
formation in the vessel wall. Human studies, suggesting
endothelial cell activation, have demonstrated increased ex-
pression of intercellular adhesion molecule-1 and vascular
cell adhesion molecule-1 in patients with TA [20]. Humoral
immunity may also play a role in the pathogenesis. Anti-
monocyte antibodies and anti-endothelial cell antibodies are
present in patients with TA and correlate with disease activ-
ity [8]. Genetic susceptibility to TA has been extensively
studied. A significant association with HLA B-52 and DR-2
was demonstrated in Japanese patients, but this finding was
not confirmed in the western countries [28, 39]. Rarely has
TA also been associated with other autoimmune diseases
such as glomerulonephritis, systemic lupus erythematosus,
juvenile idiopathic arthritis, anterior uveitis, sarcoidosis,
seronegative spondyloarthropathy, Crohn’s disease, Wege-
ner’s granulomatosis, Sweet syndrome, and ulcerative coli-
tis, which may indicate immune mechanisms in the
pathogenesis [1, 6, 9, 18, 33, 34, 40, 43, 51]. Further inves-
tigations are still required to elucidate the pathogenesis of
Takayasu arteritis. Considering arterial lesion location, on
the basis of angiographic findings, TA is divided into six
types [35] (Table 2).
There are some differences in the sites affected by in-
flammatory process among different ethnic groups. Japa-
nese patients with TA have a higher incidence of aortic
arch involvement, whereas in patients from Korea, India,
and western countries, the abdominal aorta and renal arteries
are most frequently affected. However, all patterns of vas-
cular changes have been detected in every country [39].
Clinical manifestations of TA are nonspecific. The clinical
course of the disease is divided into an early active inflam-
matory phase and late chronic phase. The active phase lasts
for weeks to months and may have a remitting and relapsing
course. It is characterized by systemic disease with symp-
toms of fever, general malaise, night sweats, loss of appetite,
weight loss, headaches, dizziness, arthralgia, skin rashes,
Fig. 2 SCTA examination—
secondary 2D and 3D
reconstructions. a Vessel
analysis protocol—thickened
aortic wall with slightly
narrowed lumen of DAo; b
volumetric reconstruction view
of branches of aortic arch with
occluded L CCA and L SCA
marked with arrows
Fig. 1 Spiral computed tomography angiography examination, cross-
section slices presenting circumferential thickening of aortic wall. a
Level of AAo and DAo with slightly thickened wall of proximal
section of pulmonary trunk; b level of aortic arch with nonenhanced
LI T A ;c proximal sections of aortic arch branches with occluded L
CCA and L SCA; d widening of R VA, lack of opacification of L VA
and L CCA (marked with arrows). AAo ascending aorta, AA aortic
arch, DAo descending aorta, BCT brachiocephalic trunk, CCA common
carotid artery (L left, R right), SCA subclavian artery (L left, R right),
VA vertebral artery (L left, R right), ITA internal thoracic artery (L left, R
right), PT pulmonary trunk
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constitutional symptoms are often seen in children with
TA. It should be highlighted that the correct diagnosis of
TA is seldom made in the early phase. Evidence of vessel
inflammation such as tenderness along arteries, bruits, and
aneurysm may point to the diagnosis of TA [28]. The late
chronic phase is the result of arterial stenosis and/or occlu-
sion and ischemia of organs. Its clinical manifestations are
varied and related to the location of arterial lesions [28, 39],
as presented in Table 3.
It should be remembered that, although TA has been
described in patients of all races, reports of Caucasian
patients in Europe are infrequent [2]. Therefore, key data
concerning the condition, both in adults and in children,
come from experience in Asian as well as South African
and South American countries. At present, TA in chil-
dren is diagnosed on the basis of the criteria proposed by
European League Against Rheumatism—Pediatric Rheu-
matology International Trials Organization—Pediatric
Rheumatology European Society, Ankara 2008 [41], pre-
sented in Table 4.
In our patient, all the above-mentioned criteria were
met. On the basis of the SCTA examination, TA of type
IIb, with pulmonary trunk involvement, was recognized.
In our patient case, the initial inflammatory phase of TA
did not occur. The onset of her disease was undetec<
table, and severe systolic arterial hypertension, which
was revealed accidentally, was the predominant clinical
manifestation.
Pathogenesis of arterial hypertension due to TA is com-
plex, multifactorial, and not fully understood. At present, it
is thought to be the result of three mechanisms: (a) mechan-
ical, in which hypertension proximal to narrowed aorta
(atypical coarctation) is due to high resistance to cardiac
output imposed by narrowing [12]; (b) neural, in which
hypertension proximal to narrowed aorta results from aortic
arch baroreceptors readjustment and this allows to ensure
adequate blood supply to organs distal to narrowed aorta
[19]; and (c) hormonal, in which hypertension is caused by
Table 1 The results of SCTA examination
Sites of measurement Diameter (mm) z score
￿ Ascending aorta 29 3.87
￿ First transverse segment 20
￿ Second transverse segment 19
￿ The isthmic region 14 −1.87
￿ The minimal diameter of the descending aorta 8 −4.77 (below 3 percentile)
Abnormalities
￿ Smooth external outline of the aorta, irregular internal outline, and laminar calcification in the ascending aorta wall
￿ Thickened walls of brachiocephalic trunk, right common carotid artery proximal portion (about 7 cm in length), and right subclavian artery
proximal portion (about 1 cm in length) with narrowed lumina
￿ Complete occlusion of the left common carotid artery and the left subclavian artery
￿ Collateral circulation on the thoracic wall and parathyroid vessels
￿ Slight thickening of the pulmonary trunk wall
￿ Normal abdominal aorta and renal arteries
Measurements and observed abnormalities
Table 2 Angiography-based categories
Type The vessels involved
Type I Branches of the aortic arch
Type IIa Ascending aorta, aortic arch, and its branches
Type IIb Type IIa region and thoracic descending aorta
Type III Thoracic descending aorta, abdominal aorta, and/or
renal arteries
Type IV Abdominal aorta and/or renal arteries
Type V Entire aorta and its branches
Table 3 Clinical features of Takayasu arteritis related to ischemia
The vessels involved Clinical features
1. Aortic branches Malaise, decreased or absent pulse of upper
extremities, dysfunction of upper
extremities, headaches, dizziness, vision
and orientation disturbances, syncope
[25, 48]
2. Aortic arch Congestive heart failure, aortic valve
insufficiency, arterial hypertension
[13, 14, 29]
3. Coronary arteries Ischemic heart disease, myocardial infarction
[4, 11]
4. Pulmonary arteries Chest pain, dyspnea, coughing, hemoptysis,
congestive heart failure [22]
5. Abdominal aorta
or celiac trunk
Ischemia of the stomach and intestines,
abdominal pain, nausea, vomiting [45]
6. Renal arteries Arterial hypertension, chronic renal failure
[5, 7, 15]
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renal arteries or aorta alone [12, 39]. A decrease in elasticity
of arterial walls observed in TA may also contribute to the
elevation of the blood pressure [37]. In our patient, systolic
arterial hypertension seemed to result from narrowing of
thoracic aorta, renal ischemia, and probably aortic arch
baroreceptors’ hyposensitivity. It should be emphasized that
in TA, blood pressure may be over- or underestimated
because alternation in wave pulse propagation occurs when
cephalad arteries of the aortic arch and both subclavian
arteries are affected [48].
The clinical spectrum at presentation of children with
Takayasu arteritis differs from that of adults. However,
hypertension is the most common sign in both groups [8].
The clinical studies in three large series of pediatric cases
from Mexico [10], India [46], and South Africa [16] have
revealed that systemic symptoms are seen in a high propor-
tion of children with TA. The usual presenting symptoms
are due to hypertension, heart failure, or a neurological
event. Claudication, bruit, and a missing pulse in an asymp-
tomatic child are uncommon presentations [28], although
those symptoms were present in our patient and they were
crucial for establishing the diagnosis.
Suspected TA mandates vascular imaging. While the intra-
arterial angiography still remains the standard for diagnosis
and evaluation of Takayasu arteritis, it has been largely
replaced by computed tomography angiography or magnetic
resonance angiography (MRA). These techniques, in addition
to visualizing the arterial lumen, may provide valuable infor-
mation about inflammation in the arterial wall and periarterial
structures. This might facilitatethe diagnosis of TA at anearly
stage, in which arterial wall thickening is present and the
lumen diameter is preserved [3, 42]. The other investigative
modalities, such as gallium-67 radionuclide scanning and
positron emission tomography utilizing 18F-FDG, are cur-
rently in vogue when evaluating such patients [8, 31], al-
though they are not widely available yet. It should be
emphasized that despite the significant advance in noninva-
sive imaging modalities over past decade, detailed medical
history and thorough physical examination still remainimpor-
tant for clinical diagnosis.
Treatment of TA is based on the use of immunosuppres-
sants such as prednisone and/or methotrexate to decrease or
eliminate inflammatory activity. About 60% of pediatric
patients with TA respond to glucocorticoids. However, as
many as 40% relapse on tapering steroids. Alternative ther-
apies such as azathioprine, cyclophosphamide, mycopheno-
late mofetil, and tacrolimus hydrate are also used in TA,
especially for corticosteroid-resistant disease [8, 20, 28, 39].
Hypertension should be treated aggressively often with
multidrug regimen, but pediatricians should be warned
against ACE inhibitors until renal artery stenosis has been
excluded.
In the presence of symptomatic stenotic or occlusive
lesions, endovascular revascularization procedures like by-
pass grafts, patch angioplasty, endarterectomy, percutaneous
transluminal angioplasty, or stent placement should be taken
into consideration [15, 49, 50]. The status of such treatment
is controversial in the literature. Despite providing short-
term benefit, endovascular revascularization procedures are
associated with a high failure rate in patients with Takayasu
arteritis. Published results suggest that these procedures
should be undertaken with great care and be reserved for
specific indications. Both, surgical and endovascular, treat-
ments become risky and achieve poorer outcomes, if they
are undertaken during a period of inflammatory activity [31,
36, 47].
Anti-inflammatory therapy can lead to a dramatic
improvement in TA. The 5-year survival rate in adults
is as high as 94% [21]. The mortality rate in children,
t h o u g h ,i sa sh i g ha s3 5 %[ 32]. Increasing knowledge
of the pathogenesis of Takayasu arteritis might eventu-
ally lead to novel-targeted therapies, such as antitumor
necrosis factor agents. Although early diagnosis holds
the key to improved outcome, a novel biological ap-
proach to treatment might prove more effective and be
potentially less toxic than the immunosuppressive regi-
ments used at present [31, 38].
Table 4 The diagnostic criteria for Takayasu arteritis in children
The mandatory criterion
The presence of an angiographic abnormality, i.e., aneurysm/dilatation, narrowing, occlusion or thickened arterial wall not due to fibromuscular
dysplasia and shown by conventional angiography, spiral computed tomography angiography or MRA of the aorta or its main branches and
pulmonary arteries
In addition to the mandatory criterion, at least one of the five following criteria must be met:
Pulse deficit (lost, decreased, unequal) or claudication (focal muscle pain induced by physical activity)
Discrepancy of four limb systolic blood pressure >10 mmHg difference in any limb
Audible vascular bruits or palpable thrills over large arteries
Arterial hypertension (systolic and/or diastolic blood pressure greater than 95th centile for patient’s age, gender, and height)
Elevation of acute phase reactant (erythrocyte sedimentation rate >20 mm per first hour or serum C-reactive protein of any value above normal
according to the local laboratory)
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